Matinas BioPharma announces LNC research evaluation with top global pharma company
Matinas BioPharma announced an agreement with an undisclosed top global pharmaceutical company aimed to evaluate synergistic effects of Matinas’ lipid-nano-crystal platform delivery technology with their partner’s nucleic acid polymer technology. January 10, 2019